Actionable news
0
All posts from Actionable news
Actionable news in VRX: VALEANT PHARMACEUTICALS INTERNATIONAL,

The Going Has Been Tough for John Paulson Lately — Here Are 3 Bright Spots in His Portfolio

Hedge fund billionaire John Paulson has seen better days.

Bloomberg reported last week that his Paulson & Co.'s main merger fund fell by 6% in September, cutting its 2015 gain to just 0.6%. Paulson's Advantage Fund, which bets on companies undergoing corporate events such as bankruptcies and spinoffs, lost 8.5% and is down 12% for the year (not that 2015 has been particularly kind to hedge funds, which are poised to have their worst year since 2011).

Paulson was dealt another blow when Valeant Pharmaceuticals (VRX...


More